Early plasma exposure after a first dose of ribavirin in HIV-HCV coinfected patients compared with HCV monoinfected patients

被引：0
|
作者：
Hatu, Giorgiana [1 ]
Pradat, Pierre [1 ]
Pourcelot, Emmanuel [2 ]
Maynard-Muet, Marianne [1 ]
Bailly, Francois [1 ]
Miailhes, Patrick [1 ]
Zoulim, Fabien [1 ]
Gagnieu, Marie-Claude [2 ]
机构：
[1] Hop Croix Rousse, Hosp Civils Lyon, F-69317 Lyon, France
[2] Hop Edouard Herriot, Hosp Civils Lyon, Lyon, France
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1917
引用
收藏
页码：1134A / 1134A
页数：1
相关论文
共 50 条
  • [1] Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients
    Monto, Alexander
    Kakar, Sanjay
    Dove, Lorna M.
    Bostrom, Alan
    Miller, Erica L.
    Wright, Teresa L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07): : 1509 - 1515
  • [2] ANTIRETROVIRALS REDUCE RIBAVIRIN EXPOSURE IN HIV-HCV COINFECTED PATIENTS
    Quioc, Jean-Jacques
    Jullien, Vincent
    Mallet, Vincent
    Nalpas, Bertrand
    Pol, Stanislas
    HEPATOLOGY, 2008, 48 (04) : 874A - 874A
  • [3] Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
    Hatu, Giorgiana
    Bailly, Francois
    Pourcelot, Emmanuel
    Pradat, Pierre
    Miailhes, Patrick
    Maynard, Marianne
    Parant, Francois
    Chiarello, Pierre
    Livrozet, Jean-Michel
    Zoulim, Fabien
    Gagnieu, Marie-Claude
    BMC INFECTIOUS DISEASES, 2014, 14
  • [4] Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
    Giorgiana Hatu
    François Bailly
    Emmanuel Pourcelot
    Pierre Pradat
    Patrick Miailhes
    Marianne Maynard
    François Parant
    Pierre Chiarello
    Jean-Michel Livrozet
    Fabien Zoulim
    Marie-Claude Gagnieu
    BMC Infectious Diseases, 14
  • [5] Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients
    Zylberberg, H
    Benhamou, Y
    Chaix, ML
    Fontaine, H
    Rouzioux, C
    Katlama, C
    Poynard, T
    Bréchot, C
    Pol, S
    JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
  • [6] Hepatic steatosis in HIV-HCV coinfected patients in France:: comparison with HCV monoinfected patients matched for body mass index and HCV genotype
    Castera, L.
    Loko, M. A.
    Le Bail, B.
    Coffie, P.
    De Ledinghen, V.
    Trimoulet, P.
    Winnock, M.
    Dabis, F.
    Neau, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (11-12) : 1489 - 1498
  • [7] Lower Ribavirin Plasma Concentrations in HCV/HIV-Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage
    Deenen, Maarten J.
    de Kanter, Clara T. M. M.
    Dofferhoff, Anthonius S. M.
    Grintjes-Huisman, Karin J. T.
    van der Ven, Andre J. A. M.
    Fleuren, Hanneke W. H. A.
    Gisolf, Elizabeth H.
    Koopmans, Peter P.
    Drenth, Joost P. H.
    Burger, David M.
    THERAPEUTIC DRUG MONITORING, 2015, 37 (06) : 751 - 755
  • [8] Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV-HCV coinfected patients, irrespective of liver disease severity
    Feuth, Thijs
    Van Baarle, Debbie
    Hoepelman, Andy I. M.
    Van Erpecum, Karel J.
    Siersema, Peter D.
    Arends, Joop E.
    APOPTOSIS, 2014, 19 (07) : 1128 - 1135
  • [9] Cellular Activation and Intracellular HCV Load in Peripheral Blood Monocytes Isolated from HCV Monoinfected and HIV-HCV Coinfected Patients
    Dichamp, Isabelle
    Abbas, Wasim
    Kumar, Amit
    Di Martino, Vincent
    Herbein, Georges
    PLOS ONE, 2014, 9 (05):
  • [10] HIV-HCV coinfected patients, followed prospectively for a mean of 4.2 years, have similar rates of death or cirrhosis compared to HCV monoinfected patients.
    Monto, A
    Dove, LM
    Seal, KH
    Miller, E
    Lebel, A
    Shen, H
    Tracy, D
    Wright, TL
    HEPATOLOGY, 2004, 40 (04) : 692A - 693A
12345